Influence of Software Tool and Methodological Aspects of Total Metabolic Tumor Volume Calculation on Baseline [18F]FDG PET to Predict Survival in Hodgkin Lymphoma
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
AIM: To investigate the respective influence of software tool and total metabolic tumor volume (TMTV0) calculation method on prognostic stratification of baseline 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography ([18F]FDG-PET) in newly diagnosed Hodgkin lymphoma (HL). METHODS: 59 patients with newly diagnosed HL were retrospectively included. [18F]FDG-PET was performed before any treatment. Four sets of TMTV0 were calculated with Beth Israel (BI) software: based on an absolute threshold selecting voxel with standardized uptake value (SUV) >2.5 (TMTV02.5), applying a per-lesion threshold of 41% of the SUV max (TMTV041) and using a per-patient adapted threshold based on SUV max of the liver (>125% and >140% of SUV max of the liver background; TMTV0125 and TMTV0140). TMTV041 was also determined with commercial software for comparison of software tools. ROC curves were used to determine the optimal threshold for each TMTV0 to predict treatment failure. RESULTS: Median follow-up was 39 months. There was an excellent correlation between TMTV041 determined with BI and with the commercial software (r = 0.96, p<0.0001). The median TMTV0 value for TMTV041, TMTV02.5, TMTV0125 and TMTV0140 were respectively 160 (used as reference), 210 ([28;154] p = 0.005), 183 ([-4;114] p = 0.06) and 143 ml ([-58;64] p = 0.9). The respective optimal TMTV0 threshold and area under curve (AUC) for prediction of progression free survival (PFS) were respectively: 313 ml and 0.70, 432 ml and 0.68, 450 ml and 0.68, 330 ml and 0.68. There was no significant difference between ROC curves. High TMTV0 value was predictive of poor PFS in all methodologies: 4-years PFS was 83% vs 42% (p = 0.006) for TMTV02.5, 83% vs 41% (p = 0.003) for TMTV041, 85% vs 40% (p<0.001) for TMTV0125 and 83% vs 42% (p = 0.004) for TMTV0140. CONCLUSION: In newly diagnosed HL, baseline metabolic tumor volume values were significantly influenced by the choice of the method used for determination of volume. However, no significant differences were found in term of prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Systematic Review of the Factors Affecting Accuracy of SUV Measurements
Adams, M. C., Turkington, T. G., Wilson, J. M., & Wong, T. Z. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.10.4923 · Cited by 662
Reference Range for Intrapatient Variability in Blood-Pool and Liver SUV for 18F-FDG PET
Boktor, R. R., Walker, G., Stacey, R., Gledhill, S., & Pitman, A. G. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.108530 · Cited by 90 · cited 1×
“The second advantage is the adaptation of the threshold value to each patient, avoiding the reproducibility issue of a fixed SUV value threshold [16,22] that could be an important limitation in multicenter trial.”
Background
Cited by
Meignan, M., Cottereau, A. S., Versari, A., Chartier, L., Dupuis, J., Boussetta, S., Grassi, I., Casasnovas, R.-O., Haioun, C., Tilly, H., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.9440 · Cited by 326
Ilyas, H., Mikhaeel, N. G., Dunn, J. T., Rahman, F., Møller, H., Smith, D., & Barrington, S. F. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-3953-z · Cited by 150
Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma
Mettler, J., Müller, H., Voltin, C.-A., Baues, C., Klaeser, B., Moccia, A., Borchmann, P., Engert, A., Kuhnert, G., Drzezga, A., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.210047 · Cited by 89
Cottereau, A.-S., Hapdey, S., Chartier, L., Modzelewski, R., Casasnovas, O., Itti, E., Tilly, H., Vera, P., Meignan, M. A., & Becker, S. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.180406 · Cited by 64
“(18) have compared 41% SUVmax threshold to a per-patient adapted threshold based on SUVmax of the liver (.”
BackgroundSelf-citation
Metadata
- Authors
- Kanoun, S., Tal, I., Berriolo-Riedinger, A., Rossi, C., Riedinger, J.-M., Vrigneaud, J.-M., Legrand, L., Humbert, O., Casasnovas, O., Brunotte, F., & Cochet, A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-10-16
- Volume
- 10
- Issue
- 10
- Pages
- e0140830
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2206977664
- Cited by
- 112
- References
- 2
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Influence of Software Tool and Methodological Aspects of Total Metabolic Tumor Volume Calculation on Baseline [18F]FDG PET to Predict Survival in Hodgkin Lymphoma. https://app.cochat.ai/papers/10.1371/journal.pone.0140830
- The paper
- Kanoun, S., Tal, I., Berriolo-Riedinger, A., Rossi, C., Riedinger, J.-M., Vrigneaud, J.-M., Legrand, L., Humbert, O., Casasnovas, O., Brunotte, F., & Cochet, A. (2015). Influence of Software Tool and Methodological Aspects of Total Metabolic Tumor Volume Calculation on Baseline [18F]FDG PET to Predict Survival in Hodgkin Lymphoma. PLOS ONE. https://doi.org/10.1371/journal.pone.0140830
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.